Quality of life and cost-effectiveness assessment of radioiodine ablation strategies in patients with thyroid cancer: Results from the randomized phase III ESTIMABL trial

DEANDREIS, Desiree';
2015-01-01

2015
33
26
2885
2892
http://jco.ascopubs.org/content/33/26/2885.full.pdf+html
Health Resources; Humans; Iodine Radioisotopes; Quality-Adjusted Life Years; Recombinant Proteins; Thyroid Neoplasms; Thyrotropin; Cost-Benefit Analysis; Quality of Life; Medicine (all); Oncology; Cancer Research
Borget, Isabelle; Bonastre, Julia; Catargi, Bogdan; Déandréis, Désirée; Zerdoud, Slimane; Rusu, Daniela; Bardet, Stéphane; Leenhardt, Laurence; Bastie...espandi
File in questo prodotto:
File Dimensione Formato  
Borget JCO 2015.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 1.94 MB
Formato Adobe PDF
1.94 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1615204
Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 61
  • ???jsp.display-item.citation.isi??? 56
social impact